An Interview with Dr. Peter Lipsky, Co-Founder, AMPEL BioSolutions LLC.

Recent Posts

• Monitoring Lupus with Data: a discussion with Dr. Schneider(Stanford) & Dr. Grammer (AMPEL’s LuGENE Flare Blood Test)
• Leveraging RNA Analytics and AI to Deliver Personalized, Effective Treatments for Complex Conditions
• AMPEL develops a blood test for cardiovascular disease
• New Blood Test Can Predict Heart Disease and Guide Prophylactic Treatment
• Precision Medicine Blood Test Predicts Heart Disease Before It Occurs
• AMPEL BioSolutions: Precision Medicine Blood Testing Predicts Heart Disease and Therapeutic Intervention
• Translating Discoveries into a Precision Health Business
• Transforming Digital Health with Genomic Data and AI